Effect of body mass index on chemoradiation outcomes in head and neck cancer

Laryngoscope

Volumn 118, Issue 7, 2008, Pages 1180-1185

  Mcrackan, Theodore R ^a   Watkins, John M ^a   Herrin, Amy E ^b   Garrett Mayer, Elizabeth M ^b   Sharma, Anand K ^a   Day, Terry A ^a   Gillespie, M Boyd ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Body mass index; Combined modality therapy; Gastrostomy; Head and neck neoplasms; Organ preservation

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CARCINOMA; INDEPENDENT VARIABLE; LARYNX CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SEX RATIO; SMOKING; SQUAMOUS CELL CARCINOMA; STOMACH TUBE; SWALLOWING; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR RECURRENCE; ENTERIC FEEDING; GASTROSTOMY; LARYNX TUMOR; MIDDLE AGED; MORTALITY; OROPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; RADIATION DOSE FRACTIONATION; STATISTICS; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY MASS INDEX; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ENTERAL NUTRITION; FEMALE; FOLLOW-UP STUDIES; GASTROSTOMY; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, CONFORMAL; STATISTICS AS TOPIC; SURVIVAL RATE;

EID: 47149113613     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31816fca5c     Document Type: Article

References (26)

1. National Cancer Institute. Head and neck cancer: questions and answers. Available at: http://www.cancer.gov/cancertopics/factsheet/Sites-Types/head-and- neck. Accessed September 4, 2007.
2. Schmalbach CE, Chepeha DB, Giordano TJ, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:295-302.
3. Monnerat C, Faivre S, Temam S, et al. End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol 2002;13:995-1006.
4. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-1690.
5. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349: 2091-2098.
6. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-2086.
7. Nguyen NP, Sallah S, Karlsson U, et al. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer 2002;94:1131-1141.
8. Nguyen NP, Moltz CC, Frank C, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 2004;15:383-388.
9. Gillespie MB, Brodsky MB, Day TA, et al. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 2004;114:1362-1367.
10. Portaluri M, Fucilli FI, Castagna R, et al. Three-dimensional conformal radiotherapy for locally advanced (stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation. Int J Radiat Oncol Biol Phys 2006;66:1036-1043.
11. Frowen JJ, Perry AR. Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review. Head Neck 2006;28:932-944.
12. Park SM, Lim MK, Shin SA, et al. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 2006;24:5017-5024.
13. Nguyen NP, North D, Smith HJ, et al. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol 2006;15:199-203.
14. Cooper JS, Fu K, Marks J, et al. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 2003;55:213-321.
15. Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation. Int J Radiat Oncol Biol Phys 1996;36:469-480.
16. Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005;61:772-778.
17. Campbell BH, Spinelli K, Marbella AM, et al. Aspiration, weight loss, and quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg 2004;130: 1100-1103.
18. Dewys WD. Weight loss and nutritional abnormalities in cancer patient: incidence, severity, and significance. In: Calmar KC, Fear on KC, eds. Nutritional Support for the Cancer Patient. London, UK: WB Saunders; 1986:251-261.
19. Lees J. Incidence of weight loss in head and neck cancer patients on commencing radiotherapy at a regional oncology center. Eur J Cancer Care 1999;8:133-136.
20. Tisdale MJ. Cachexia in cancer patients. Nature 2002;2: 862-871.
21. Couch M, Lai V, Cannon T, et al. Cancer cachexia syndrome in head and neck cancer patients. Part I. Diagnosis, impact on quality of life and survival, and treatment. Head Neck 2007;29:401-411.
22. Ravasco P, Monteiro-Grillo I, Camilo ME. Does nutrition influence quality of life in cancer patients undergoing radiotherapy? Radiother Oncol 2003;67:213-220.
23. Gayle D, Ilyin SE, Plata-Salaman CR. Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats. Brain Res Bull 1997;44:311-317.
24. Camps C, Iranzo V, Bremnes RM, et al. Anorexia-cachexia syndrome in cancer: implications of the ubiquitinproteasome pathway. Supp Care Cancer 2006;14: 1173-1183.
25. Williams ML, Torres-Duarte A, Brant LJ, et al. The relationship between a urinary cachectic factor and weight loss in advanced cancer patients. Cancer Invest 2004;22:866-870.
26. Forastiere A, Koch W, Trotti A, et al. Head and neck cancer. N Engl J Med 2001;345:1890-1900.